Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway

Acquired resistance to standard therapies remains a serious challenge, requiring novel therapeutic approaches that incorporate potential factors involved in tumor resistance. As cancers including melanoma express inflammatory cyclooxygenases generating prostaglandins implicated in tumor growth, we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Thyagarajan, Anita, Saylae, Jeremiah, Sahu, Ravi P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564820/
https://www.ncbi.nlm.nih.gov/pubmed/28636992
http://dx.doi.org/10.18632/oncotarget.18326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564820/
https://www.ncbi.nlm.nih.gov/pubmed/28636992
http://dx.doi.org/10.18632/oncotarget.18326

Ejemplares similares